Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: Multiple interacting susceptibility to lung cancer (Sluc) genes with large effects

Experimental Lung Research

Volumn 24, Issue 4, 1998, Pages 419-436

  Fijneman, Remond J A ^a   Van Der Valk, Martin A ^a   Demant, Peter ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Alveolar; Genetics; Lung tumors; Mouse; N ethyl N nitrosourea; Papillary; Quantitative trait loci; Recombinant congenic strains; Sluc genes

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOMAL INHERITANCE; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; INBRED STRAIN; LUNG ALVEOLUS CELL; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0031831695     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149809087378     Document Type: Conference Paper

References (62)

1. Eng C, Ponder BA. The role of gene mutations in the genesis of familial cancers. FASEB J. 1993; 7:910-919.
2. Peto J. Genetic predisposition to cancer. In: Cairns J, Lyon JL, Skolnick M, eds. Cancer Incidence in Defined Populations. CSH, Banbury report; 1980: 203-213.
3. Heston WE. Genetic analysis of susceptibility to induced pulmonary tumors in mice. J Natl Cancer Inst. 1942; 3:69-78.
4. Heston WE. Inheritance of susceptibility to spontaneous pulmonary tumors in mice. J Natl Cancer Inst. 1942; 3:79-82.
5. Diwan BA. Meier H. Strain- and age-dependent transplacental carcinogenesis by 1-ethyl-1-nitrosourea in inbred strains of mice. Cancer Res. 1974; 34:764-767.
6. van der Valk MA. Survival, tumor incidence and gross pathology in 33 mouse strains. In: Hilgers J, Sluyser M, eds. Mammary Tumors in the Mouse. Amsterdam: Elsevier/North-Holland Biomedical; 1981: 46-115.
7. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54:594-606.
8. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 55:891-903.
9. Ryan J, Barker PE, Nesbitt MN, Ruddle FH. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J Natl Cancer Inst. 1987; 79:1351-1357.
10. Gariboldi M, Manenti G, Canzian F, et al. A major lung tumor susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nature Genet. 1993, 3:132-136.
11. Devereux TR, Wiseman RW, Kaplan N, et al. Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mammalian Genome. 1994; 5:749-755.
12. Festing MFW, Yang A, Malkinson AM. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet Res Camb. 1994; 64:99-106.
13. Manenti G, Gariboldi M, Elango R, et al. Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouse. Nature Genet. 1996; 12:455-457.
14. You M, Yang Y, Stoner G, et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA. 1992; 89:5804-5808.
15. Fijneman RJA, Ophoff RA, Hart AAM, Demant P. K-ras-2 alleles, mutations, and lung tumor susceptibility in the mouse: an evaluation. Oncogene. 1994; 9:1417-1421.
16. Chen B, Johanson L, Wiest JS, Anderson MW, You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA. 1994; 91:1589-1593.
17. Demant P, Hart AAM. Recombinant congenic strains: a novel tool for analyzing genetic traits determined by more than one gene. Immunogenetics. 1986; 24:416-422.
18. Jansen RC. Complex plant traits: time for polygenic analysis. Trends Plant Sci. 1996; 1:89-94.
19. Fijneman RJA, de Vries SS, Jansen RC, Demant P. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3 and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nature Genet. 1996; 14:465-467.
20. Moen CJA, van der Valk MA, Snoek M, et al. The recombinant congenic strains: a novel genetic tool applied to the study of colon tumor development in the mouse. Mammalian Genome. 1991; 1:217-227.
21. Mori N, Okumoto M, van der Valk MA, et al. Genetic dissection of susceptibility to radiation-induced apoptosis of thymocytcs and mapping of Rapopl, a novel susceptibility gene. Genomics. 1995; 25:609-614.
22. Lipoldova M, Kosarova M, Zajicova A, et al. Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics. 1995; 41:301-311.
23. Moen CJA, Snoek M, Hart AAM, Demant P. Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene. 1992; 7:563-566.
24. Moen CJA, Groot PC, Hart AAM, Snoek M, Demant P. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci USA. 1996; 93:1082-1086.
25. van Wezel T, Stassen APM, Moen CJA, Hart AAM, van der Valk MA, Demant P. Gene interaction and single gene effects in colon tumor susceptibility in mice. Nature Genet. 1996; 14:468-470.
26. Mori N, Okumoto M, Hart AAM, Demant P. Apoptosis susceptibility genes on mouse chromosome 9 (Rapop2) and chromosome 3 (Rapop3). Genomics. 1995; 30:553-557.
27. Krulova M, Havelkova H, Kosarova M, et al. IL-2-induccd proliferatiec response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics. 1997; 42:11-15.
28. Havelkova H, Krulova M, Kosarova M, et al. Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. Immunogenetics. 1996; 44:475-477.
29. Fijneman RJA, Jansen RC, van der Valk MA, Demant P. Dissection of a complex quantitative genetic trait: multiple interactions and ten new lung cancer susceptibility loci, Sluc5 to Sluc14. Submitted.
30. Oomen LCJM, van der Valk MA, Demant P. MHC and non-MHC genes in lung tumor susceptibility in the mouse: implications for the study of the different lung tumor types and their cell of origin. Exp Lung Res. 1991; 17:283-304.
31. Obata M, Nishimori H, Katsuhiro O, Lee G-H. Identification of the Par2 (pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene. 1996; 13:1599-1604.
32. Kauffman SL, Alexander L, Sass L. Histologic and ultrastructural features of the Clara cell adenoma of the mouse lung. Lab Invest. 1979; 40:708-716.
33. den Engelse L, Oomen LCJM, van der Valk MA, Hart AAM, Dux A. Studies on lung tumours, V: susceptibility of mice to dimethylnitrosamine-induced tumour formation in relation to H-2 haplotype. Int J Cancer. 1981; 28:199-208.
34. Oomen LCJM, Dernant P, Hart AAM, Emmelot P. Multiple genes in the H-2 complex affect differently the number and growth rate of transplacentally induced lung tumours in mice. Int J Cancer. 1983; 31:447-454.
35. Beer DG, Malkinson AM. Genetic influence on type 2 or Clara cell origin of pulmonary adenomas in urethan-treated mice.J Natl Cancer Inst. 1985; 75:963-969.
36. Heston WE, Dunn TB. Tumor development in susceptible strain A and resistant strain L lung transplants in LAF1 hosts. J Natl Cancer Inst. 1951; 11:1057-1071.
37. Shapiro JR, Kirschbaum A. Intrinsic tissue response to induction of lung transplants. Cancer Res. 1951; 11:644-647.
38. Mintz B, Custer RP, Donnelly AJ. Genetic diseases and developmental defects analyzed in allophenic mice. In: Richter GW, Epstein MA, eds. International Review of Experimental Pathology, Vol 10. New York: Academic; 1971: 143-179.
39. Heston WE. Genetics in neoplasia. In: Burdette WJ ed. Methodology in Mammalian Genetics. San Francisco: Holden-Day; 1963: 247-268.
40. Murphy ED. Characteristic tumors. In: Green EL, ed. Biology of the Laboratory Mouse, New York: McGraw-Hill; 1966:521-570.
41. Dux A, Demant P. MHC-controlled susceptibility to C3H-MTV-induced mouse mammary tumors is predominantly systemic rather than local. Int J Cancer. 1987; 40: 372-377.
42. 2 synthase. Nature Structural Biol. 1995; 2:637-643.
43. Rosenberg L, Palmer JR, Zauber AG, Warshauer EM, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991; 83:355-358.
44. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993; 328:1313-1316.
45. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 1996; 56:710-714.
46. Jalbert G, Castonguay A. Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett. 1992; 66:21-28.
47. Potter M, Wax JS, Anderson AO, Nordan RP. Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J Exp Med. 1985; 161:996-1012.
48. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996; 87:803-809.
49. Min-induced intestinal neoplasia. Cell. 1995; 81:957-966.
50. Mock BA, Krall MM, Dosik JK. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci USA. 1993; 90:9499-9503.
51. Poole TM, Drinkwater NR. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones. Proc Natl Acad Sci USA. 1996; 93:5848-5853.
52. Drinkwater NP. Genetic control of hepatocarcinogenesis in C3H mice. Drug Metab Rev. 1994; 26:201-218.
53. Manenti G, Binelli G, Gariboldi M, et al. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics. 1994; 23:118-124.
54. Shisa H, Yamada Y, Kawarai A, et al. Genetic and epigenetic resistance of SL/Ni mice to lymphomas. Jpn J Cancer Res. 1996; 87:258-262.
55. Lee GH, Bennett LM, Carabeo RA, Drinkwater NR. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics. 1995; 139:387-395.
56. Fijneman RJA, Demant P. A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4. Cancer Res. 1995; 55:3179-3182.
57. Dietrich W, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell. 1993; 75:631-639.
58. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nature Genet. 1995; 10:424-429.
59. Gariboldi M, Manenti G, Canzian F, et al. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 1993; 53:209-211.
60. Yamada Y, Shisa H, Matsushiro H, et al. T lymphomagenesis is determined by a dominant gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models. J Exp Med. 1994; 180:2155-2162.
61. Jacoby RF, Hohman C, Marshall DJ, et al. Genetic analysis of colon cancer susceptibility in mice. Genomics. 1994, 22:381-387.
62. Pataer A, Kamoto T, Lu L-M, Yamada Y, Hiai H. Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms. Cancer Res. 1996; 56:3716-3720.